Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000269620> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2000269620 endingPage "220" @default.
- W2000269620 startingPage "208" @default.
- W2000269620 abstract "Approximately one in three people with diabetes is affected by diabetic distal symmetric sensorimotor polyneuropathy (DSPN), which represents a major health problem as it may present with excruciating neuropathic pain and is responsible for substantial morbidity, increased mortality and impaired quality of life. Neuropathic pain causes considerable interference with sleep, daily activities, and enjoyment of life. Treatment is based on four cornerstones: (1) intensive diabetes therapy and multifactorial risk intervention; (2) treatment based on pathogenetic mechanisms; (3) symptomatic treatment; and (4) avoidance of risk factors and complications. Recent experimental studies suggest a multifactorial pathogenesis of diabetic neuropathy. From the clinical point of view, it is important to note that, based on these pathogenetic mechanisms, therapeutic approaches could be derived, some of which are currently being evaluated in clinical trials. Management of chronic painful DSPN remains a challenge for the physician and should consider the following practical rules: the appropriate and effective drug has to be tried and identified in each patient by carefully titrating the dosage based on efficacy and side effects; lack of efficacy should be judged only after 2 – 4 weeks of treatment using an adequate dosage. Analgesic combination therapy may be useful, and potential drug interactions have to be considered given the frequent polypharmacy in people with diabetes. Not only increased alcohol consumption but also the traditional cardiovascular risk factors such as visceral obesity, hypertension, hyperlipidemia and smoking have a role in the development and progression of diabetic neuropathy and hence need to be prevented or treated. Keywords: Distal symmetric polyneuropathy, Neuropathic pain, Glycemic control, Pathogenetic treatment, Antidepressants, Anticonvulsants, Opioids, Non-pharmacological treatment, Normal glucose tolerance (NGT), Impaired fasting glucose (IFG), Small Fiber Neuropathy (SFN)" @default.
- W2000269620 created "2016-06-24" @default.
- W2000269620 creator A5091487204 @default.
- W2000269620 date "2011-05-01" @default.
- W2000269620 modified "2023-10-03" @default.
- W2000269620 title "Current Concepts in the Management of Diabetic Polyneuropathy" @default.
- W2000269620 doi "https://doi.org/10.2174/157339911795843113" @default.
- W2000269620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21534920" @default.
- W2000269620 hasPublicationYear "2011" @default.
- W2000269620 type Work @default.
- W2000269620 sameAs 2000269620 @default.
- W2000269620 citedByCount "45" @default.
- W2000269620 countsByYear W20002696202012 @default.
- W2000269620 countsByYear W20002696202013 @default.
- W2000269620 countsByYear W20002696202014 @default.
- W2000269620 countsByYear W20002696202015 @default.
- W2000269620 countsByYear W20002696202016 @default.
- W2000269620 countsByYear W20002696202017 @default.
- W2000269620 countsByYear W20002696202018 @default.
- W2000269620 countsByYear W20002696202019 @default.
- W2000269620 countsByYear W20002696202020 @default.
- W2000269620 countsByYear W20002696202021 @default.
- W2000269620 countsByYear W20002696202022 @default.
- W2000269620 crossrefType "journal-article" @default.
- W2000269620 hasAuthorship W2000269620A5091487204 @default.
- W2000269620 hasConcept C126322002 @default.
- W2000269620 hasConcept C134018914 @default.
- W2000269620 hasConcept C141071460 @default.
- W2000269620 hasConcept C159110408 @default.
- W2000269620 hasConcept C177713679 @default.
- W2000269620 hasConcept C1862650 @default.
- W2000269620 hasConcept C2775892965 @default.
- W2000269620 hasConcept C2777107010 @default.
- W2000269620 hasConcept C2779178840 @default.
- W2000269620 hasConcept C2779951463 @default.
- W2000269620 hasConcept C36434225 @default.
- W2000269620 hasConcept C42219234 @default.
- W2000269620 hasConcept C535046627 @default.
- W2000269620 hasConcept C555293320 @default.
- W2000269620 hasConcept C71924100 @default.
- W2000269620 hasConceptScore W2000269620C126322002 @default.
- W2000269620 hasConceptScore W2000269620C134018914 @default.
- W2000269620 hasConceptScore W2000269620C141071460 @default.
- W2000269620 hasConceptScore W2000269620C159110408 @default.
- W2000269620 hasConceptScore W2000269620C177713679 @default.
- W2000269620 hasConceptScore W2000269620C1862650 @default.
- W2000269620 hasConceptScore W2000269620C2775892965 @default.
- W2000269620 hasConceptScore W2000269620C2777107010 @default.
- W2000269620 hasConceptScore W2000269620C2779178840 @default.
- W2000269620 hasConceptScore W2000269620C2779951463 @default.
- W2000269620 hasConceptScore W2000269620C36434225 @default.
- W2000269620 hasConceptScore W2000269620C42219234 @default.
- W2000269620 hasConceptScore W2000269620C535046627 @default.
- W2000269620 hasConceptScore W2000269620C555293320 @default.
- W2000269620 hasConceptScore W2000269620C71924100 @default.
- W2000269620 hasIssue "3" @default.
- W2000269620 hasLocation W20002696201 @default.
- W2000269620 hasLocation W20002696202 @default.
- W2000269620 hasOpenAccess W2000269620 @default.
- W2000269620 hasPrimaryLocation W20002696201 @default.
- W2000269620 hasRelatedWork W1563850031 @default.
- W2000269620 hasRelatedWork W1580303020 @default.
- W2000269620 hasRelatedWork W2256896035 @default.
- W2000269620 hasRelatedWork W2526382513 @default.
- W2000269620 hasRelatedWork W2805057031 @default.
- W2000269620 hasRelatedWork W3034611108 @default.
- W2000269620 hasRelatedWork W3091389974 @default.
- W2000269620 hasRelatedWork W4251999242 @default.
- W2000269620 hasRelatedWork W4297944757 @default.
- W2000269620 hasRelatedWork W4300487847 @default.
- W2000269620 hasVolume "7" @default.
- W2000269620 isParatext "false" @default.
- W2000269620 isRetracted "false" @default.
- W2000269620 magId "2000269620" @default.
- W2000269620 workType "article" @default.